Starling Oncology (STLNW) FCF Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 300.00 |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -27.00 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 153.00 |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 826.00 |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -143.00 |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -540.00 |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | -248.00 |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -259.00 |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -247.00 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 1,636.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,636.00 |
| Mar 31, 2026 | 288.00 |
| Dec 31, 2025 | -71.00 |
| Sep 30, 2025 | -1,091.00 |
| Jun 30, 2025 | 821.00 |
| Mar 31, 2025 | 1,233.00 |
| Dec 31, 2024 | 778.00 |
| Sep 30, 2024 | 1,249.00 |
| Jun 30, 2024 | -578.00 |
| Mar 31, 2024 | 527.00 |
| Dec 31, 2023 | 1,685.00 |
| Sep 30, 2023 | 2,196.00 |
| Jun 30, 2023 | 728.00 |
| Mar 31, 2023 | 991.00 |
| Dec 31, 2022 | 2,389.00 |
| Sep 30, 2022 | -2,628.00 |
| Jun 30, 2022 | -412.00 |
| Mar 31, 2022 | -3,228.00 |